I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Identification of FDA approved drugs against SARS-CoV-2 RNA..:
Zahra Molavi
;
Sara Razi
;
Seyed Amir Mirmotalebisohi
...
http://www.sciencedirect.com/science/article/pii/S0753332221003292. , 2021
Link:
https://doi.org/10.1016/j.biopha.2021.111544
RT Journal T1
Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:ff692cea7cef401db2fb74205770f6e9&Exemplar=1&LAN=DE A1 Zahra Molavi A1 Sara Razi A1 Seyed Amir Mirmotalebisohi A1 Amirjafar Adibi A1 Marzieh Sameni A1 Farshid Karami A1 Vahid Niazi A1 Zahra Niknam A1 Morteza Aliashrafi A1 Mohammad Taheri A1 Soudeh Ghafouri-Fard A1 Shabnam Jeibouei A1 Soodeh Mahdian A1 Hakimeh Zali A1 Mohammad Mehdi Ranjbar A1 Mohsen Yazdani PB Elsevier YR 2021 K1 SARS-CoV-2 K1 COVID-19 K1 Drug repurposing K1 FDA-approved drugs K1 RdRp K1 3CLpro K1 Therapeutics. Pharmacology K1 RM1-950 JF http://www.sciencedirect.com/science/article/pii/S0753332221003292 LK http://dx.doi.org/https://doi.org/10.1016/j.biopha.2021.111544 DO https://doi.org/10.1016/j.biopha.2021.111544 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)